CDEK
← All organizations
Scilex Pharms Inc

Scilex Pharms Inc

For profitWebsite ↗

Also known as: SCILEX HLDG | Scilex Ltd. | Scilex Pharmaceuticals, Inc. | SCILEX PHARMS | SCILEX PHARMS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Apr 28, 2014

First marketed drug

Feb 28, 2018

Last known activity

Jan 6, 2022

Acquired by Sorrento Therapeutics, Inc. on Nov 8, 2016

Timeline

2010s

  1. Jun 1, 2011

    Scilex Pharms Inc— Founded

  2. Nov 8, 2016

    Sorrento Therapeutics, Inc.— Acquired By

  3. Feb 28, 2018

    lidocaine— NDA Secondary Org

2020s

  1. May 5, 2020

    celecoxib— Marketing Organization

Drugs by trial phase (3 distinct, 14 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (3)

Recent trials (15)

Details

Founded
San Diego, CA, US Jun 1, 2011
Last known activity
Jan 6, 2022